2018
DOI: 10.3961/jpmph.18.070
|View full text |Cite
|
Sign up to set email alerts
|

Researches of Epigenetic Epidemiology for Infections and Radiation as Carcinogen

Abstract: In recent years, a number of studies have been reported on the various types of cancer arising from epigenetic alterations, including reports that these epigenetic alterations occur as a result of radiation exposure or infection. Thyroid cancer and breast cancer, in particular, have high cancer burden, and it has been confirmed that radiation exposure or onco-viral infection are linked to increased risk of development of these two types of cancer, respectively. Thus, the environment-epigenetic alteration-cance… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 26 publications
0
3
0
1
Order By: Relevance
“…To date, the USA FDA has approved four HDACis, including vorinostat (SAHA, 2006), romidepsin (FK228, 2009), belinostat (PXD101, 2014) and panobinostat (LBH-589, 2015), which are widely used as anticancer drugs, especially for refractory cutaneous and peripheral T cell lymphoma and multiple melanoma. Increasing evidence suggests that epigenetic alternations (DNA methylation, acetylation and chromatin modification) play key roles in thyroid cancer development, as well as cancer cell growth and differentiation [6,7,8,9,10]. Previous studies have shown that epigenetic modification causes gene silencing, which substantially decreases the responsiveness of thyroid tumors to radioiodine therapy [11,12,13].…”
Section: Introductionmentioning
confidence: 99%
“…To date, the USA FDA has approved four HDACis, including vorinostat (SAHA, 2006), romidepsin (FK228, 2009), belinostat (PXD101, 2014) and panobinostat (LBH-589, 2015), which are widely used as anticancer drugs, especially for refractory cutaneous and peripheral T cell lymphoma and multiple melanoma. Increasing evidence suggests that epigenetic alternations (DNA methylation, acetylation and chromatin modification) play key roles in thyroid cancer development, as well as cancer cell growth and differentiation [6,7,8,9,10]. Previous studies have shown that epigenetic modification causes gene silencing, which substantially decreases the responsiveness of thyroid tumors to radioiodine therapy [11,12,13].…”
Section: Introductionmentioning
confidence: 99%
“…La exposición a agentes biológicos infecciosos en la infancia se asocia con un mayor riesgo de malignidad a través del curso de la vida, relacionado a la inmadurez fisiológica y la vulnerabilidad en las etapas críticas del desarrollo (65) . La IARC identificó agentes biológicos potencialmente carcinogénicos en humanos con características y comportamiento específicos dependiendo de las condiciones socioeconómicas que faciliten la infección durante la infancia (33) .…”
Section: Agentes Biológicosunclassified
“…The mechanistic control of active DNA demethylation is further contributory evidence for an involved course in the creation, paradoxically, of CpG Island methylation series of patterns that further constitute dimensions of repression of suppressor tumor genes in particular. A number of studies have reported the various types of cancer arising from epigenetic alteration, including epigenetic alterations occurring as a result of radiation exposure or infection [8]. Proposed increment in evolutionary control is linked intrinsically to an overall hypomethylation as borne out by dimensions of dynamic equilibrium between methylation and de-methylation.…”
Section: Cell Replicationmentioning
confidence: 99%